4,5-Dichloro-2-(trifluoromethyl)quinazoline

Catalog No.: 
ACKISM242
CAS No.: 
1603341-18-9
Molecular Formula: 
C9H3Cl2F3N2
Molecular Weight: 
267.04
4,5-Dichloro-2-(trifluoromethyl)quinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$96.00InquiryInquiry
1g95%$299.00InquiryInquiry
5g95%$1465.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5-Dichloro-2-(trifluoromethyl)quinazoline
IUPAC Name4,5-dichloro-2-(trifluoromethyl)quinazoline
Molecular FormulaC9H3Cl2F3N2
Molecular Weight267.04
SMILESFC(F)(F)C1N=C2C(C(=CC=C2)Cl)=C(Cl)N=1
InChI KeyMGJTZBRTQSGGKF-UHFFFAOYSA-N
SynonymQuinazoline, 4,5-dichloro-2-(trifluoromethyl)-;4,5-dichloro-2-(trifluoromethyl)quinazoline
CAS No.1603341-18-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H320-H335
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACKISM242 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIFE921 route compound structure diagram
    ACLIFE921134517-55-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKISM242 route product structure diagram
    ACKISM2421603341-18-9
Inquiry

2. ACKISM242 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKISM242 route product structure diagram
    ACKISM2421603341-18-9
Inquiry

3. ACKISM242 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKISM242 route product structure diagram
    ACKISM2421603341-18-9
Inquiry

Comments (0)